Skip to main content
OpenTrials
Completed

NCT Number: NCT03690349

Mold Sensitization Associated Severe Asthma Exacerbation

Mold sensitization is associated with severe asthma exacerbation.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Mold sensitization has been reported to be one of the factors that is associated with severe asthma exacerbation (SAE). The objective is to identify the factors that are associated with SAE in asthmatic children particularly mold sensitization.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Asthmatic children aged 1-15 years old from Pediatric Allergy and Immunology division with hospitalized due to severe asthma exacerbation in a preceding year and without severe asthma exacerbation in a preceding year

Exclusion criteria

  • Other serious systemic diseases, pregnant, lactation

Treatment and study plan

Skin test

Other

Demographic data review, Disease severity evaluation, Treatment evaluation and Skin prick test for 16 common aeroallergens

Primary outcomes

  1. Association between mold sensitization and severe asthma exacerbation

    Time frame: 1 year

    Compare mean wheal diameter (mm.) of skin prick test of mold allergen extracts between the group with severe asthma exacerbation and the group without severe asthma exacerbation

Sponsors and collaborators

Lead sponsor

Mahidol University

Other

Registry information

Official study title

Is Mold Sensitization Associated With Severe Asthma Exacerbation in Children?

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Oct 1, 2018
Registry last updated
Mar 15, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.